Delivery Order SPE2DB20D3103-SPE2DB25FL3S7
Award Date
10/15/24
Potential Completion Date
10/16/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,316.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cyclophosphamide 1 gm/5 ml vials, a pharmaceutical product used in the treatment of various medical conditions. The contract is a firm fixed-price delivery order with a performance period extending through May 14, 2025. The contract is not set-aside and was...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclophosphamide 2 gm/10 ml vials. The contract has a ceiling value of $3,053.00 and a completion date of June 23, 2025. It is a firm-fixed-price contract and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,553.88, is for the delivery of 4,568,075,876 units of the drug Cyclophosphamide 500 mg vials. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 30, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is the prime...
This federal contract award is for the delivery of Cyclophosphamide 2 GM vials to support healthcare programs administered by the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm fixed-price delivery order contract with a ceiling value of $10,761.60 and a completion date of September 1, 2022. The contract does not have a set-aside designation, indicating it was awarded through full and open...
This contract award to Amerisourcebergen Drug Corp is for the delivery of Cyclophosphamide 1 GM vials, a critical pharmaceutical product. The $2,873.22 firm fixed-price Delivery Order was issued by the Defense Logistics Agency (DLA), a major defense agency responsible for providing medical supplies and pharmaceuticals to military treatment facilities and other federal healthcare providers. The contract has a period of performance through July 23, 2024 and was not set aside for any specific...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 500 mg vials of the medication Cyclophosphamide, with a ceiling value of $1,973.19 and a performance period ending on June 13, 2025. The award is not set-aside and represents an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 2 gram vials of the medication Cyclophosphamide, with a ceiling value of $8,983.68 and a period of performance through June 24, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,156.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,517,983 units of Ifosfamide 3 GM Vials, a type of chemotherapy medication, with a completion date of February 2, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
This federal contract award is for the delivery of pharmaceutical products and medical supplies to the U.S. government. The contract, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has a ceiling value of $25,656.54 and a completion date of September 3, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC...
This federal contract award is for the delivery of pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,313.49 and an ultimate completion date of October 24, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., the parent company, which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...